FMP
NASDAQ
Inactive Equity
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.
1.95 USD
0 (0%)
Valuation Date:
Dec 27, 2022 4:00 PM
Share Price on Valuation Date
$1.95
Stock Beta
0
Shares Outstanding
0